WormBase Tree Display for RNAi: WBRNAi00071109

WBRNAi00071109 Homol: Homol_homol: Y71G12B:RNAi
  Sequence_info: PCR_product: sjj_Y71G12A_195.c
  Experiment: Laboratory: RT
    Date: 16 Jul 2007 00:00:00
    Genotype: bIs1(vit-2::GFP); rrf-3(pk1426)
    Temperature: 20
    Delivered_by: Bacterial_feeding
  Inhibits: Predicted_gene: Y71G12B.11a Inferred_automatically: RNAi_primary
      Y71G12B.11e Inferred_automatically: RNAi_primary
      Y71G12B.11d Inferred_automatically: RNAi_primary
      Y71G12B.11c Inferred_automatically: RNAi_primary
    Gene: WBGene00006771 Inferred_automatically: RNAi_primary
    Transcript: Y71G12B.11c.1 Inferred_automatically: RNAi_primary
      Y71G12B.11e.1 Inferred_automatically: RNAi_primary
      Y71G12B.11a.1 Inferred_automatically: RNAi_primary
      Y71G12B.11d.1 Inferred_automatically: RNAi_primary
      Y71G12B.11b.1 Inferred_automatically: RNAi_primary
  Species: Caenorhabditis elegans
  Reference: WBPaper00030951
  Phenotype: WBPhenotype:0000961 Remark: RNAi treatment resulted in an abnormal accumulation of YP170-GFP in the body cavity.
    WBPhenotype:0001425 Remark: RNAi treatment resulted in strong suppression of yolk uptake by oocytes as judged by the abnormal accumulation of YP170-GFP in the body cavity.
  Remark: Primary screen. L4 larval stage was applied to induced RNAi cultures.
  Method: RNAi